Literature DB >> 23242635

Production of tag-free recombinant fusion protein encompassing promiscuous T cell epitope of tetanus toxoid and dog zona pellucida glycoprotein-3 for contraceptive vaccine development.

Neha Gupta1, Abhinav Shrestha, Amulya Kumar Panda, Satish Kumar Gupta.   

Abstract

Affinity tags can interfere in various physicochemical properties and immunogenicity of the recombinant proteins. In the present study, tag-free recombinant fusion protein encompassing promiscuous T cell epitope of tetanus toxoid [TT; amino acid (aa) residues 830-844] followed by dilysine linker and dog zona pellucida glycoprotein-3 (ZP3; aa residues 23-348) (TT-KK-ZP3) was expressed in Escherichia coli. The recombinant protein, expressed as inclusion bodies (IBs), was purified by isolation of IBs, processed to remove host cell proteins, followed by solubilization and refolding. A specific 39 kDa protein including ZP3 was identified by SDS-PAGE. CD spectra showed the presence of α-helices and β-sheets, and fluorescent spectroscopy revealed emission maxima of 265 A.U. at 339 nm for refolded protein and showed red shift in the presence of 6 M guanidine hydrochloride. Immunization of inbred FvB/J female mice with purified recombinant TT-KK-ZP3 (25 μg/animal) led to generation of high antibody titers against the recombinant protein. The antibodies reacted specifically with ZP matrix surrounding mouse oocytes. Immunized mice showed significant reduction in fertility as compared to the control group. The studies described herein provide a simple method to produce and purify tag-free recombinant protein for the development of a contraceptive vaccine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23242635     DOI: 10.1007/s12033-012-9634-4

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  36 in total

Review 1.  Protein refolding for industrial processes.

Authors:  E D Clark
Journal:  Curr Opin Biotechnol       Date:  2001-04       Impact factor: 9.740

Review 2.  A closer look at proteolysis and MHC-class-II-restricted antigen presentation.

Authors:  Ana-Maria Lennon-Duménil; Arnold H Bakker; Paula Wolf-Bryant; Hidde L Ploegh; Cécile Lagaudrière-Gesbert
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

3.  The effect of amino acid spacers on the antigenicity of dimeric peptide--inducing cross-reacting antibodies to a cell surface protein antigen of Streptococcus mutans.

Authors:  Y Oishi; A Onozuka; H Kato; N Shimura; S Imai; T Nisizawa
Journal:  Oral Microbiol Immunol       Date:  2001-02

Review 4.  Zona pellucida-based contraceptive vaccines for human and animal utility.

Authors:  Satish K Gupta; N Gupta; P Suman; S Choudhury; K Prakash; T Gupta; R Sriraman; S B Nagendrakumar; V A Srinivasan
Journal:  J Reprod Immunol       Date:  2011-03-05       Impact factor: 4.054

5.  Ovarian histopathology of bitches immunized with porcine zonae pellucidae.

Authors:  C A Mahi-Brown; R Yanagimachi; M L Nelson; H Yanagimachi; N Palumbo
Journal:  Am J Reprod Immunol Microbiol       Date:  1988-11

Review 6.  Rationale and prospects for rabies elimination in developing countries.

Authors:  F X Meslin; D B Fishbein; H C Matter
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

7.  Expression and purification of recombinant human zona pellucida proteins.

Authors:  J D Harris; C A Seid; G K Fontenot; H F Liu
Journal:  Protein Expr Purif       Date:  1999-07       Impact factor: 1.650

8.  Identification and evaluation of an infertility-associated ZP3 epitope from the marsupial brushtail possum (Trichosurus vulpecula).

Authors:  Xianlan Cui; Janine A Duckworth; Frank C Molinia; Phil E Cowan
Journal:  Vaccine       Date:  2009-12-05       Impact factor: 3.641

9.  Detergent binding explains anomalous SDS-PAGE migration of membrane proteins.

Authors:  Arianna Rath; Mira Glibowicka; Vincent G Nadeau; Gong Chen; Charles M Deber
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

10.  Evaluation of the contraceptive potential of recombinant human ZP3 and human ZP3 peptides in a primate model: their safety and efficacy.

Authors:  M Paterson; M R Wilson; K D Morris; M van Duin; R J Aitken
Journal:  Am J Reprod Immunol       Date:  1998-09       Impact factor: 3.886

View more
  5 in total

Review 1.  Milestones in contraceptive vaccines development and hurdles in their application.

Authors:  Satish Kumar Gupta; Abhinav Shrestha; Vidisha Minhas
Journal:  Hum Vaccin Immunother       Date:  2013-11-21       Impact factor: 3.452

Review 2.  Infertility and Immunocontraception based on zona pellucida.

Authors:  Akiko Hasegawa; Hiroyuki Tanaka; Hiroaki Shibahara
Journal:  Reprod Med Biol       Date:  2013-06-29

3.  Ovarian Oxidative Stress Induced Follicle Depletion After Zona Pellucida 3 Vaccination Is Associated With Subfertility in BALB/c Mice.

Authors:  Beibei Zhang; Guanggang Qu; Yuchen Nan; En-Min Zhou
Journal:  Front Vet Sci       Date:  2022-02-18

4.  Evaluation of Stress Accompanying Immunocontraceptive Vaccination in Donkeys.

Authors:  Erik W Peterson; Lorenzo G T M Segabinazzi; Robert O Gilbert; Don R Bergfelt; Hilari M French
Journal:  Animals (Basel)       Date:  2022-02-13       Impact factor: 2.752

5.  The preclinical evaluation of immunocontraceptive vaccines based on canine zona pellucida 3 (cZP3) in a mouse model.

Authors:  Ying Wang; Yijie Li; Beibei Zhang; Fuchun Zhang
Journal:  Reprod Biol Endocrinol       Date:  2018-05-11       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.